Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)
The National Cancer Institute is offering funding to support research on developing a vaccine for Kaposi sarcoma herpesvirus (KSHV). The goal is to create a vaccine that can either prevent infection and diseases related to KSHV, like Kaposi sarcoma and multicentric Castleman disease, or treat those already infected. Research can include identifying targets for the vaccine, creating animal mode…
Through this Notice of Funding Opportunity Announcement (NOFO), the National Cancer Institute (NCI) intends to expand the research scope and leverage the gains made through the NOFO entitled Investigation of the Transmission of KSHV (RFA-CA-18-013 and RFA-CA-20-046) to support basic and translat…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers